[HTML][HTML] Pharmacogenomics of old and new immunosuppressive drugs for precision medicine in kidney transplantation
S Turolo, A Edefonti, ML Syren, G Montini - Journal of Clinical Medicine, 2023 - mdpi.com
Kidney transplantation is the preferred therapeutic option for end-stage kidney disease, but,
despite major therapeutic advancements, allograft rejection continues to endanger graft …
despite major therapeutic advancements, allograft rejection continues to endanger graft …
[PDF][PDF] Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation
S Turolo, A Edefonti, ML Syren, G Montini - J. Clin. Med, 2023 - pdfs.semanticscholar.org
Kidney transplantation is the preferred therapeutic option for end-stage kidney disease, but,
despite major therapeutic advancements, allograft rejection continues to endanger graft …
despite major therapeutic advancements, allograft rejection continues to endanger graft …
Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation.
S Turolo, A Edefonti, ML Syren… - Journal of Clinical …, 2023 - search.ebscohost.com
Kidney transplantation is the preferred therapeutic option for end-stage kidney disease, but,
despite major therapeutic advancements, allograft rejection continues to endanger graft …
despite major therapeutic advancements, allograft rejection continues to endanger graft …
Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation.
S Turolo, A Edefonti, ML Syren… - Journal of Clinical …, 2023 - europepmc.org
Kidney transplantation is the preferred therapeutic option for end-stage kidney disease, but,
despite major therapeutic advancements, allograft rejection continues to endanger graft …
despite major therapeutic advancements, allograft rejection continues to endanger graft …
Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation
S Turolo, A Edefonti, ML Syren… - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Kidney transplantation is the preferred therapeutic option for end-stage kidney disease, but,
despite major therapeutic advancements, allograft rejection continues to endanger graft …
despite major therapeutic advancements, allograft rejection continues to endanger graft …
Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation
S Turolo, A Edefonti, ML Syren… - Journal of Clinical …, 2023 - search.proquest.com
Kidney transplantation is the preferred therapeutic option for end-stage kidney disease, but,
despite major therapeutic advancements, allograft rejection continues to endanger graft …
despite major therapeutic advancements, allograft rejection continues to endanger graft …
[HTML][HTML] Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation
S Turolo, A Edefonti, ML Syren… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
Kidney transplantation is the preferred therapeutic option for end-stage kidney disease, but,
despite major therapeutic advancements, allograft rejection continues to endanger graft …
despite major therapeutic advancements, allograft rejection continues to endanger graft …
[PDF][PDF] Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation
S Turolo, A Edefonti, ML Syren, G Montini - J. Clin. Med, 2023 - academia.edu
Kidney transplantation is the preferred therapeutic option for end-stage kidney disease, but,
despite major therapeutic advancements, allograft rejection continues to endanger graft …
despite major therapeutic advancements, allograft rejection continues to endanger graft …